Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · AKRON, OH · NPI 1407958556
Verified facts
CMS Open Payments records show Jeffrey David Kile, MD received $18.36 in general payments during 2025 across 1 reported records.
Cranial Technologies, Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Cranial Technologies, Inc | Unresolved — no canonical attribution shown | $18.36 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.36 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Doc Band Normalized: doc band |
Device | Cranial Technologies, Inc | $18.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 321 | 112 |
| Levothyroxine Sodium | Levothyroxine Sodium | 285 | 76 |
| Omeprazole | Omeprazole | 223 | 61 |
| Lisinopril | Lisinopril | 214 | 72 |
| Gabapentin | Gabapentin | 207 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 202 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 193 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 172 | 61 |
| Fluoxetine Hcl | Fluoxetine Hcl | 157 | 43 |
| Losartan Potassium | Losartan Potassium | 151 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 141 | 43 |
| Pregabalin | Pregabalin | 140 | 25 |
| Metformin Hcl Er | Metformin Hcl | 132 | 47 |
| Prednisone | Prednisone | 119 | 78 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 40 |
| Pantoprazole Sodium | Pantoprazole Sodium | 103 | 33 |
| Amlodipine Besylate | Amlodipine Besylate | 100 | 39 |
| Ipratropium Bromide | Ipratropium Bromide | 98 | 39 |
| Montelukast Sodium | Montelukast Sodium | 94 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 93 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 35 |
| Tramadol Hcl | Tramadol Hcl | 82 | 18 |
| Eliquis | Apixaban | 80 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | 17 |
| Furosemide | Furosemide | 77 | 27 |
| Trazodone Hcl | Trazodone Hcl | 75 | 16 |
| Potassium Chloride | Potassium Chloride | 72 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 71 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 69 | 56 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 65 | 17 |
| Spironolactone | Spironolactone | 65 | 12 |
| Azithromycin | Azithromycin | 62 | 52 |
| Sertraline Hcl | Sertraline Hcl | 60 | 31 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 55 | 40 |
| Finasteride | Finasteride | 55 | 16 |
| Alprazolam | Alprazolam | 54 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 51 | 19 |
| Clonazepam | Clonazepam | 50 | 12 |
| Allopurinol | Allopurinol | 49 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 47 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 25 |
| Divalproex Sodium | Divalproex Sodium | 46 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 46 | 12 |
| Metformin Hcl | Metformin Hcl | 46 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 46 | 16 |
| Amoxicillin | Amoxicillin | 44 | 36 |
| Clopidogrel | Clopidogrel Bisulfate | 43 | 16 |
| Lorazepam | Lorazepam | 43 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 42 | 23 |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 32 |
| Clindamycin Hcl | Clindamycin Hcl | 39 | 24 |
| Levofloxacin | Levofloxacin | 38 | 32 |
| Diazepam | Diazepam | 37 | 15 |
| Lactulose | Lactulose | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Meloxicam | Meloxicam | 35 | 13 |
| Carvedilol | Carvedilol | 34 | 14 |
| Terazosin Hcl | Terazosin Hcl | 34 | 12 |
| Topiramate | Topiramate | 34 | suppressed |
| Fluconazole | Fluconazole | 33 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 32 | 12 |
| Ozempic | Semaglutide | 32 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | 11 |
| Buspirone Hcl | Buspirone Hcl | 30 | suppressed |
| Celecoxib | Celecoxib | 30 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | 13 |
| Trulicity | Dulaglutide | 30 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 30 | 13 |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 24 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Haloperidol | Haloperidol | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 20 |
| Ezetimibe | Ezetimibe | 25 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 25 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 25 | suppressed |
| Simvastatin | Simvastatin | 25 | 11 |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Temazepam | Temazepam | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 20 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 20 | suppressed |
| Famotidine | Famotidine | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | 15 |
| Nystatin | Nystatin | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Carisoprodol | Carisoprodol | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 11 |
| Risperidone | Risperidone | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Nabumetone | Nabumetone | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Levocarnitine | Levocarnitine | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.36 · 1 records | Cranial Technologies, Inc | Doc Band | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error